1 Market Overview

1.1 Product Overview and Scope of HIV Diagnostics

1.2 Classification of HIV Diagnostics by Type

1.2.1 Overview: Global HIV Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global HIV Diagnostics Revenue Market Share by Type in 2020

1.2.3 Consumables

1.2.4 Assay, Kits and Reagents

1.2.5 Other Consumables

1.2.6 Instruments

1.2.7 Software and Services

1.3 Global HIV Diagnostics Market by Application

1.3.1 Overview: Global HIV Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Antibody Tests

1.3.3 Viral Load Tests

1.3.4 CD4 Tests

1.3.5 Tests for Early Infant Diagnosis

1.3.6 Tests for Viral Identification

1.4 Global HIV Diagnostics Market Size & Forecast

1.5 Global HIV Diagnostics Market Size and Forecast by Region

1.5.1 Global HIV Diagnostics Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global HIV Diagnostics Market Size by Region, (2016-2021)

1.5.3 North America HIV Diagnostics Market Size and Prospect (2016-2026)

1.5.4 Europe HIV Diagnostics Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific HIV Diagnostics Market Size and Prospect (2016-2026)

1.5.6 South America HIV Diagnostics Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa HIV Diagnostics Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 HIV Diagnostics Market Drivers

1.6.2 HIV Diagnostics Market Restraints

1.6.3 HIV Diagnostics Trends Analysis

2 Company Profiles

2.1 Abbott

2.1.1 Abbott Details

2.1.2 Abbott Major Business

2.1.3 Abbott HIV Diagnostics Product and Solutions

2.1.4 Abbott HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Abbott Recent Developments and Future Plans

2.2 Abbott Healthcare

2.2.1 Abbott Healthcare Details

2.2.2 Abbott Healthcare Major Business

2.2.3 Abbott Healthcare HIV Diagnostics Product and Solutions

2.2.4 Abbott Healthcare HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Abbott Healthcare Recent Developments and Future Plans

2.3 Abbvie Inc.

2.3.1 Abbvie Inc. Details

2.3.2 Abbvie Inc. Major Business

2.3.3 Abbvie Inc. HIV Diagnostics Product and Solutions

2.3.4 Abbvie Inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Abbvie Inc. Recent Developments and Future Plans

2.4 Brsitol-Myers Squibb

2.4.1 Brsitol-Myers Squibb Details

2.4.2 Brsitol-Myers Squibb Major Business

2.4.3 Brsitol-Myers Squibb HIV Diagnostics Product and Solutions

2.4.4 Brsitol-Myers Squibb HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Brsitol-Myers Squibb Recent Developments and Future Plans

2.5 Janssen Therapeutics

2.5.1 Janssen Therapeutics Details

2.5.2 Janssen Therapeutics Major Business

2.5.3 Janssen Therapeutics HIV Diagnostics Product and Solutions

2.5.4 Janssen Therapeutics HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Janssen Therapeutics Recent Developments and Future Plans

2.6 Gilead Sciences

2.6.1 Gilead Sciences Details

2.6.2 Gilead Sciences Major Business

2.6.3 Gilead Sciences HIV Diagnostics Product and Solutions

2.6.4 Gilead Sciences HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Gilead Sciences Recent Developments and Future Plans

2.7 Merck & Co. Inc

2.7.1 Merck & Co. Inc Details

2.7.2 Merck & Co. Inc Major Business

2.7.3 Merck & Co. Inc HIV Diagnostics Product and Solutions

2.7.4 Merck & Co. Inc HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Merck & Co. Inc Recent Developments and Future Plans

2.8 VIIV Healthcare

2.8.1 VIIV Healthcare Details

2.8.2 VIIV Healthcare Major Business

2.8.3 VIIV Healthcare HIV Diagnostics Product and Solutions

2.8.4 VIIV Healthcare HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 VIIV Healthcare Recent Developments and Future Plans

2.9 BD Biosciences

2.9.1 BD Biosciences Details

2.9.2 BD Biosciences Major Business

2.9.3 BD Biosciences HIV Diagnostics Product and Solutions

2.9.4 BD Biosciences HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 BD Biosciences Recent Developments and Future Plans

2.10 Beckman Coulter

2.10.1 Beckman Coulter Details

2.10.2 Beckman Coulter Major Business

2.10.3 Beckman Coulter HIV Diagnostics Product and Solutions

2.10.4 Beckman Coulter HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Beckman Coulter Recent Developments and Future Plans

2.11 Partec

2.11.1 Partec Details

2.11.2 Partec Major Business

2.11.3 Partec HIV Diagnostics Product and Solutions

2.11.4 Partec HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Partec Recent Developments and Future Plans

2.12 Sysmex

2.12.1 Sysmex Details

2.12.2 Sysmex Major Business

2.12.3 Sysmex HIV Diagnostics Product and Solutions

2.12.4 Sysmex HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Sysmex Recent Developments and Future Plans

2.13 Apogee Flow Systems

2.13.1 Apogee Flow Systems Details

2.13.2 Apogee Flow Systems Major Business

2.13.3 Apogee Flow Systems HIV Diagnostics Product and Solutions

2.13.4 Apogee Flow Systems HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Apogee Flow Systems Recent Developments and Future Plans

2.14 PointCare Technologies Inc.

2.14.1 PointCare Technologies Inc. Details

2.14.2 PointCare Technologies Inc. Major Business

2.14.3 PointCare Technologies Inc. HIV Diagnostics Product and Solutions

2.14.4 PointCare Technologies Inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 PointCare Technologies Inc. Recent Developments and Future Plans

2.15 Zyomyx Inc.

2.15.1 Zyomyx Inc. Details

2.15.2 Zyomyx Inc. Major Business

2.15.3 Zyomyx Inc. HIV Diagnostics Product and Solutions

2.15.4 Zyomyx Inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Zyomyx Inc. Recent Developments and Future Plans

2.16 Mylan inc.

2.16.1 Mylan inc. Details

2.16.2 Mylan inc. Major Business

2.16.3 Mylan inc. HIV Diagnostics Product and Solutions

2.16.4 Mylan inc. HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Mylan inc. Recent Developments and Future Plans

2.17 Roche Diagnostics

2.17.1 Roche Diagnostics Details

2.17.2 Roche Diagnostics Major Business

2.17.3 Roche Diagnostics HIV Diagnostics Product and Solutions

2.17.4 Roche Diagnostics HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Roche Diagnostics Recent Developments and Future Plans

2.18 Siemens Healthcare

2.18.1 Siemens Healthcare Details

2.18.2 Siemens Healthcare Major Business

2.18.3 Siemens Healthcare HIV Diagnostics Product and Solutions

2.18.4 Siemens Healthcare HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Siemens Healthcare Recent Developments and Future Plans

2.19 Qiagen

2.19.1 Qiagen Details

2.19.2 Qiagen Major Business

2.19.3 Qiagen HIV Diagnostics Product and Solutions

2.19.4 Qiagen HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Qiagen Recent Developments and Future Plans

2.20 BioMerieux

2.20.1 BioMerieux Details

2.20.2 BioMerieux Major Business

2.20.3 BioMerieux HIV Diagnostics Product and Solutions

2.20.4 BioMerieux HIV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 BioMerieux Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global HIV Diagnostics Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 HIV Diagnostics Players Market Share

3.2.2 Top 10 HIV Diagnostics Players Market Share

3.2.3 Market Competition Trend

3.3 HIV Diagnostics Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global HIV Diagnostics Revenue and Market Share by Type (2016-2021)

4.2 Global HIV Diagnostics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global HIV Diagnostics Revenue Market Share by Application (2016-2021)

5.2 HIV Diagnostics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America HIV Diagnostics Revenue by Type (2016-2026)

6.2 North America HIV Diagnostics Revenue by Application (2016-2026)

6.3 North America HIV Diagnostics Market Size by Country

6.3.1 North America HIV Diagnostics Revenue by Country (2016-2026)

6.3.2 United States HIV Diagnostics Market Size and Forecast (2016-2026)

6.3.3 Canada HIV Diagnostics Market Size and Forecast (2016-2026)

6.3.4 Mexico HIV Diagnostics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe HIV Diagnostics Revenue by Type (2016-2026)

7.2 Europe HIV Diagnostics Revenue by Application (2016-2026)

7.3 Europe HIV Diagnostics Market Size by Country

7.3.1 Europe HIV Diagnostics Revenue by Country (2016-2026)

7.3.2 Germany HIV Diagnostics Market Size and Forecast (2016-2026)

7.3.3 France HIV Diagnostics Market Size and Forecast (2016-2026)

7.3.4 United Kingdom HIV Diagnostics Market Size and Forecast (2016-2026)

7.3.5 Russia HIV Diagnostics Market Size and Forecast (2016-2026)

7.3.6 Italy HIV Diagnostics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific HIV Diagnostics Revenue by Type (2016-2026)

8.2 Asia-Pacific HIV Diagnostics Revenue by Application (2016-2026)

8.3 Asia-Pacific HIV Diagnostics Market Size by Region

8.3.1 Asia-Pacific HIV Diagnostics Revenue by Region (2016-2026)

8.3.2 China HIV Diagnostics Market Size and Forecast (2016-2026)

8.3.3 Japan HIV Diagnostics Market Size and Forecast (2016-2026)

8.3.4 South Korea HIV Diagnostics Market Size and Forecast (2016-2026)

8.3.5 India HIV Diagnostics Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia HIV Diagnostics Market Size and Forecast (2016-2026)

8.3.7 Australia HIV Diagnostics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America HIV Diagnostics Revenue by Type (2016-2026)

9.2 South America HIV Diagnostics Revenue by Application (2016-2026)

9.3 South America HIV Diagnostics Market Size by Country

9.3.1 South America HIV Diagnostics Revenue by Country (2016-2026)

9.3.2 Brazil HIV Diagnostics Market Size and Forecast (2016-2026)

9.3.3 Argentina HIV Diagnostics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa HIV Diagnostics Revenue by Type (2016-2026)

10.2 Middle East & Africa HIV Diagnostics Revenue by Application (2016-2026)

10.3 Middle East & Africa HIV Diagnostics Market Size by Country

10.3.1 Middle East & Africa HIV Diagnostics Revenue by Country (2016-2026)

10.3.2 Turkey HIV Diagnostics Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia HIV Diagnostics Market Size and Forecast (2016-2026)

10.3.4 UAE HIV Diagnostics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global HIV Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global HIV Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market HIV Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global HIV Diagnostics Revenue (USD Million) by Region (2016-2021)

Table 5. Global HIV Diagnostics Revenue Market Share by Region (2021-2026)

Table 6. Abbott Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Major Business

Table 8. Abbott HIV Diagnostics Product and Solutions

Table 9. Abbott HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Abbott Healthcare Corporate Information, Head Office, and Major Competitors

Table 11. Abbott Healthcare Major Business

Table 12. Abbott Healthcare HIV Diagnostics Product and Solutions

Table 13. Abbott Healthcare HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Abbvie Inc. Corporate Information, Head Office, and Major Competitors

Table 15. Abbvie Inc. Major Business

Table 16. Abbvie Inc. HIV Diagnostics Product and Solutions

Table 17. Abbvie Inc. HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Brsitol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 19. Brsitol-Myers Squibb Major Business

Table 20. Brsitol-Myers Squibb HIV Diagnostics Product and Solutions

Table 21. Brsitol-Myers Squibb HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Janssen Therapeutics Corporate Information, Head Office, and Major Competitors

Table 23. Janssen Therapeutics Major Business

Table 24. Janssen Therapeutics HIV Diagnostics Product and Solutions

Table 25. Janssen Therapeutics HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Gilead Sciences Corporate Information, Head Office, and Major Competitors

Table 27. Gilead Sciences Major Business

Table 28. Gilead Sciences HIV Diagnostics Product and Solutions

Table 29. Gilead Sciences HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Merck & Co. Inc Corporate Information, Head Office, and Major Competitors

Table 31. Merck & Co. Inc Major Business

Table 32. Merck & Co. Inc HIV Diagnostics Product and Solutions

Table 33. Merck & Co. Inc HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. VIIV Healthcare Corporate Information, Head Office, and Major Competitors

Table 35. VIIV Healthcare Major Business

Table 36. VIIV Healthcare HIV Diagnostics Product and Solutions

Table 37. VIIV Healthcare HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. BD Biosciences Corporate Information, Head Office, and Major Competitors

Table 39. BD Biosciences Major Business

Table 40. BD Biosciences HIV Diagnostics Product and Solutions

Table 41. BD Biosciences HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Beckman Coulter Corporate Information, Head Office, and Major Competitors

Table 43. Beckman Coulter Major Business

Table 44. Beckman Coulter HIV Diagnostics Product and Solutions

Table 45. Beckman Coulter HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Partec Corporate Information, Head Office, and Major Competitors

Table 47. Partec Major Business

Table 48. Partec HIV Diagnostics Product and Solutions

Table 49. Partec HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Sysmex Corporate Information, Head Office, and Major Competitors

Table 51. Sysmex Major Business

Table 52. Sysmex HIV Diagnostics Product and Solutions

Table 53. Sysmex HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Apogee Flow Systems Corporate Information, Head Office, and Major Competitors

Table 55. Apogee Flow Systems Major Business

Table 56. Apogee Flow Systems HIV Diagnostics Product and Solutions

Table 57. Apogee Flow Systems HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. PointCare Technologies Inc. Corporate Information, Head Office, and Major Competitors

Table 59. PointCare Technologies Inc. Major Business

Table 60. PointCare Technologies Inc. HIV Diagnostics Product and Solutions

Table 61. PointCare Technologies Inc. HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Zyomyx Inc. Corporate Information, Head Office, and Major Competitors

Table 63. Zyomyx Inc. Major Business

Table 64. Zyomyx Inc. HIV Diagnostics Product and Solutions

Table 65. Zyomyx Inc. HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Mylan inc. Corporate Information, Head Office, and Major Competitors

Table 67. Mylan inc. Major Business

Table 68. Mylan inc. HIV Diagnostics Product and Solutions

Table 69. Mylan inc. HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Roche Diagnostics Corporate Information, Head Office, and Major Competitors

Table 71. Roche Diagnostics Major Business

Table 72. Roche Diagnostics HIV Diagnostics Product and Solutions

Table 73. Roche Diagnostics HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Siemens Healthcare Corporate Information, Head Office, and Major Competitors

Table 75. Siemens Healthcare Major Business

Table 76. Siemens Healthcare HIV Diagnostics Product and Solutions

Table 77. Siemens Healthcare HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Qiagen Corporate Information, Head Office, and Major Competitors

Table 79. Qiagen Major Business

Table 80. Qiagen HIV Diagnostics Product and Solutions

Table 81. Qiagen HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. BioMerieux Corporate Information, Head Office, and Major Competitors

Table 83. BioMerieux Major Business

Table 84. BioMerieux HIV Diagnostics Product and Solutions

Table 85. BioMerieux HIV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Global HIV Diagnostics Revenue (USD Million) by Players (2019-2021)

Table 87. Global HIV Diagnostics Revenue Share by Players (2019-2021)

Table 88. Breakdown of HIV Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 89. HIV Diagnostics Players Head Office, Products and Services Provided

Table 90. HIV Diagnostics Mergers & Acquisitions in the Past Five Years

Table 91. HIV Diagnostics New Entrants and Expansion Plans

Table 92. Global HIV Diagnostics Revenue (USD Million) by Type (2016-2021)

Table 93. Global HIV Diagnostics Revenue Share by Type (2016-2021)

Table 94. Global HIV Diagnostics Revenue Forecast by Type (2021-2026)

Table 95. Global HIV Diagnostics Revenue by Application (2016-2021)

Table 96. Global HIV Diagnostics Revenue Forecast by Application (2021-2026)

Table 97. North America HIV Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 98. North America HIV Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 99. North America HIV Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 100. North America HIV Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 101. North America HIV Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 102. North America HIV Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 103. Europe HIV Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 104. Europe HIV Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 105. Europe HIV Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 106. Europe HIV Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 107. Europe HIV Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 108. Europe HIV Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 109. Asia-Pacific HIV Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 110. Asia-Pacific HIV Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 111. Asia-Pacific HIV Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 112. Asia-Pacific HIV Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 113. Asia-Pacific HIV Diagnostics Revenue by Region (2016-2021) & (USD Million)

Table 114. Asia-Pacific HIV Diagnostics Revenue by Region (2021-2026) & (USD Million)

Table 115. South America HIV Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 116. South America HIV Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 117. South America HIV Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 118. South America HIV Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 119. South America HIV Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 120. South America HIV Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 121. Middle East & Africa HIV Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 122. Middle East & Africa HIV Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 123. Middle East & Africa HIV Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 124. Middle East & Africa HIV Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 125. Middle East & Africa HIV Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 126. Middle East & Africa HIV Diagnostics Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. HIV Diagnostics Picture

Figure 2. Global HIV Diagnostics Revenue Market Share by Type in 2020

Figure 3. Consumables

Figure 4. Assay, Kits and Reagents

Figure 5. Other Consumables

Figure 6. Instruments

Figure 7. Software and Services

Figure 8. HIV Diagnostics Revenue Market Share by Application in 2020

Figure 9. Antibody Tests Picture

Figure 10. Viral Load Tests Picture

Figure 11. CD4 Tests Picture

Figure 12. Tests for Early Infant Diagnosis Picture

Figure 13. Tests for Viral Identification Picture

Figure 14. Global HIV Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 15. Global HIV Diagnostics Revenue and Forecast (2016-2026) & (USD Million)

Figure 16. Global HIV Diagnostics Revenue Market Share by Region (2016-2026)

Figure 17. Global HIV Diagnostics Revenue Market Share by Region in 2020

Figure 18. North America HIV Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Europe HIV Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Asia-Pacific HIV Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. South America HIV Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Middle East and Africa HIV Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. HIV Diagnostics Market Drivers

Figure 24. HIV Diagnostics Market Restraints

Figure 25. HIV Diagnostics Market Trends

Figure 26. Abbott Recent Developments and Future Plans

Figure 27. Abbott Healthcare Recent Developments and Future Plans

Figure 28. Abbvie Inc. Recent Developments and Future Plans

Figure 29. Brsitol-Myers Squibb Recent Developments and Future Plans

Figure 30. Janssen Therapeutics Recent Developments and Future Plans

Figure 31. Gilead Sciences Recent Developments and Future Plans

Figure 32. Merck & Co. Inc Recent Developments and Future Plans

Figure 33. VIIV Healthcare Recent Developments and Future Plans

Figure 34. BD Biosciences Recent Developments and Future Plans

Figure 35. Beckman Coulter Recent Developments and Future Plans

Figure 36. Partec Recent Developments and Future Plans

Figure 37. Sysmex Recent Developments and Future Plans

Figure 38. Apogee Flow Systems Recent Developments and Future Plans

Figure 39. PointCare Technologies Inc. Recent Developments and Future Plans

Figure 40. Zyomyx Inc. Recent Developments and Future Plans

Figure 41. Mylan inc. Recent Developments and Future Plans

Figure 42. Roche Diagnostics Recent Developments and Future Plans

Figure 43. Siemens Healthcare Recent Developments and Future Plans

Figure 44. Qiagen Recent Developments and Future Plans

Figure 45. BioMerieux Recent Developments and Future Plans

Figure 46. Global HIV Diagnostics Revenue Share by Players in 2020

Figure 47. HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 48. Global Top 3 Players HIV Diagnostics Revenue Market Share in 2020

Figure 49. Global Top 10 Players HIV Diagnostics Revenue Market Share in 2020

Figure 50. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 51. Global HIV Diagnostics Revenue Share by Type in 2020

Figure 52. Global HIV Diagnostics Market Share Forecast by Type (2021-2026)

Figure 53. Global HIV Diagnostics Revenue Share by Application in 2020

Figure 54. Global HIV Diagnostics Market Share Forecast by Application (2021-2026)

Figure 55. North America HIV Diagnostics Sales Market Share by Type (2016-2026)

Figure 56. North America HIV Diagnostics Sales Market Share by Application (2016-2026)

Figure 57. North America HIV Diagnostics Revenue Market Share by Country (2016-2026)

Figure 58. United States HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Canada HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Mexico HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Europe HIV Diagnostics Sales Market Share by Type (2016-2026)

Figure 62. Europe HIV Diagnostics Sales Market Share by Application (2016-2026)

Figure 63. Europe HIV Diagnostics Revenue Market Share by Country (2016-2026)

Figure 64. Germany HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. France HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. United Kingdom HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Russia HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Italy HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Asia-Pacific HIV Diagnostics Sales Market Share by Type (2016-2026)

Figure 70. Asia-Pacific HIV Diagnostics Sales Market Share by Application (2016-2026)

Figure 71. Asia-Pacific HIV Diagnostics Revenue Market Share by Region (2016-2026)

Figure 72. China HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Japan HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. South Korea HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. India HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Southeast Asia HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Australia HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. South America HIV Diagnostics Sales Market Share by Type (2016-2026)

Figure 79. South America HIV Diagnostics Sales Market Share by Application (2016-2026)

Figure 80. South America HIV Diagnostics Revenue Market Share by Country (2016-2026)

Figure 81. Brazil HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Argentina HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Middle East and Africa HIV Diagnostics Sales Market Share by Type (2016-2026)

Figure 84. Middle East and Africa HIV Diagnostics Sales Market Share by Application (2016-2026)

Figure 85. Middle East and Africa HIV Diagnostics Revenue Market Share by Country (2016-2026)

Figure 86. Turkey HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 87. Saudi Arabia HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 88. UAE HIV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 89. Methodology

Figure 90. Research Process and Data Source